cangrelor: Clinical Trials

3 trials of cangrelor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow cangrelor: new trials by email Literature Review of cangrelor trials Research Report on cangrelor

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cangrelor Neonatal PK/PD and Safety Study
Cangrelor - Partial Obstruction of Systemic to Pulmonary Artery Shunt, Complete Obstruction of Systemic to Pulmonary Artery Shunt
Phase 1CompletedChiesi Farmaceutici S.p.A.222017-01-032023-02-15
Assess the Effect of Cangrelor at the Therapeutic Dose and a Supratherapeutic Dose Level on the QT/QTc Interval in Healthy Volunteers
cangrelor, moxifloxacin, placebo - Healthy
Phase 1CompletedThe Medicines Company672008-06-012012-01-18
Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor
cangrelor - Healthy
Phase 1CompletedThe Medicines Company402005-03-012011-08-16

Sponsors

The Medicines Company (2)  ·  Chiesi Farmaceutici S.p.A. (1)

Countries

United States (3)

Top investigators

Steven Steinhubl, MD (1)  ·  Thomas Diacovo, MD (1)

Results publications

PMID 23921301, PMID 33078501

NIH funding

2016 (1)